ifosfamide has been researched along with Experimental Leukemia in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Oral bioavailability in rats was 48-73% of parenteral administration, and antitumor activity in mice was equivalent by both routes." | 1.38 | Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. ( Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voelcker, G | 2 |
| Jones, B | 1 |
| Komarnitsky, P | 1 |
| Miller, GT | 1 |
| Amedio, J | 1 |
| Wallner, BP | 1 |
| Struck, RF | 1 |
| Dykes, DJ | 1 |
| Corbett, TH | 1 |
| Suling, WJ | 1 |
| Trader, MW | 1 |
| Perito, S | 1 |
| Cenci, E | 1 |
| Sbaraglia, G | 1 |
| Vecchiarelli, A | 1 |
| Pfeiffer, B | 1 |
| Schnee, A | 1 |
| Hohorst, H | 1 |
| Tsukagoshi, S | 1 |
| Brock, N | 1 |
| Pohl, J | 2 |
| Paprocka, M | 3 |
| Kuśnierczyk, H | 2 |
| Budzyński, W | 2 |
| Rak, J | 2 |
| Radzikowski, C | 3 |
| Kinas, R | 1 |
| Misiura, K | 1 |
| Stec, W | 1 |
| Blaschke, G | 1 |
| Hilgard, P | 1 |
| Maibaum, J | 1 |
| Niemeyer, U | 1 |
11 other studies available for ifosfamide and Experimental Leukemia
| Article | Year |
|---|---|
Influence of the alkylating function of aldo-Ifosfamide on the anti-tumor activity.
Topics: Animals; Antineoplastic Agents, Alkylating; DNA Damage; Female; Ifosfamide; Leukemia, Experimental; | 2018 |
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 2012 |
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide; | 1983 |
[The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II].
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; BCG Vaccine; Cyclophosphamide; Dimethoate; F | 1980 |
Increased antitumour activity of mesyl-I-aldophosphamide-perhydrothiazine, in vivo but not in vitro, compared to I-aldophosphamide-perhydrothiazine.
Topics: Animals; Antineoplastic Agents; Cell Death; Drug Screening Assays, Antitumor; Female; Ifosfamide; Le | 2000 |
[Ifomide].
Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental; | 1987 |
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Topics: Animals; Biotransformation; Cyclophosphamide; DNA; Glutathione; Ifosfamide; Kidney; Leukemia, Experi | 1986 |
Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
Topics: Animals; Cyclophosphamide; Ifosfamide; Leukemia, Experimental; Mice; Mice, Inbred Strains; Neoplasms | 1986 |
Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
Topics: Animals; Cyclophosphamide; Ifosfamide; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mice; | 1986 |
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide; | 1986 |
[Separation and pharmaco-toxicological studies of the enantiomers of Ifosfamide].
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Chromatography, Affinity; Female; Ifosfamide; Isom | 1986 |